438 related articles for article (PubMed ID: 25311592)
21. Five years renal transplantation data: Single-center experience from Iraq.
Ali AA; Al-Saedi AJ; Al-Mudhaffer AJ; Al-Taee KH
Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):341-7. PubMed ID: 26997389
[TBL] [Abstract][Full Text] [Related]
22. Short-term outcomes of Thymoglobulin induction in pediatric renal transplant recipients.
Ault BH; Honaker MR; Osama Gaber A; Jones DP; Duhart BT; Powell SL; Hays DW; Wyatt RJ
Pediatr Nephrol; 2002 Oct; 17(10):815-8. PubMed ID: 12376809
[TBL] [Abstract][Full Text] [Related]
23. Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.
Cantarovich D; Rostaing L; Kamar N; Saint-Hillier Y; Ducloux D; Mourad G; Garrigue V; Wolf P; Ellero B; Cassuto E; Albano L; Soulillou JP;
Transpl Int; 2010 Mar; 23(3):313-24. PubMed ID: 19843296
[TBL] [Abstract][Full Text] [Related]
24. Can pediatric steroid-free renal transplantation improve growth and metabolic complications?
Bhakta N; Marik J; Malekzadeh M; Gjertson D; Ettenger R
Pediatr Transplant; 2008 Dec; 12(8):854-61. PubMed ID: 18482211
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of two-drug maintenance immunosuppression for pediatric renal transplantation: 10-yr follow-up in a single center.
Michael M; Minard CG; Kale AS; Brewer ED
Pediatr Transplant; 2016 Feb; 20(1):49-58. PubMed ID: 26916966
[TBL] [Abstract][Full Text] [Related]
26. Alemtuzumab induction in pediatric kidney transplantation.
Kaabak MM; Babenko NN; Samsonov DV; Sandrikov VA; Maschan AA; Zokoev AK
Pediatr Transplant; 2013 Mar; 17(2):168-78. PubMed ID: 23442101
[TBL] [Abstract][Full Text] [Related]
27. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
29. Pediatric renal transplantation under tacrolimus-based immunosuppression.
Shapiro R; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Gilboa N; Gritsch HA; Irish W; McCauley J; Fung JJ; Hakala TR; Simmons RL; Starzl TE
Transplantation; 1999 Jan; 67(2):299-303. PubMed ID: 10075598
[TBL] [Abstract][Full Text] [Related]
30. Acute cellular rejection treatment outcomes stratified by Banff grade in pediatric kidney transplant.
Chen J; Liverman R; Garro R; Jernigan S; Travers C; Winterberg PD
Pediatr Transplant; 2019 Mar; 23(2):e13334. PubMed ID: 30537179
[TBL] [Abstract][Full Text] [Related]
31. Avoiding steroids in pediatric renal transplantation: long-term experience from a single centre.
Pedersen EB; El-Faramawi M; Foged N; Larsen KE; Jespersen B
Pediatr Transplant; 2007 Nov; 11(7):730-5. PubMed ID: 17910649
[TBL] [Abstract][Full Text] [Related]
32. Comparison between thymoglobulin and ATGAM as an induction agent in adult kidney transplantation: a single-center experience.
Kim JM; Jang HR; Ko JS; Kwon CH; Kwak MS; Hur WS; Kim SJ; Kim GS; Joh JW; Lee SK; Oh HY
Transplant Proc; 2012 Jan; 44(1):171-4. PubMed ID: 22310607
[TBL] [Abstract][Full Text] [Related]
33. Anti-lymphocyte therapy successfully controls late "cholestatic" rejection in pediatric liver transplant recipients.
Kerkar N; Morotti RA; Iyer K; Arnon R; Miloh T; Sturdevant M; Suchy F; Florman S; Emre S
Clin Transplant; 2011; 25(6):E584-91. PubMed ID: 21919961
[TBL] [Abstract][Full Text] [Related]
34. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
35. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age.
Patel SJ; Knight RJ; Suki WN; Abdellatif A; Duhart BT; Krauss AG; Mannan S; Nezakatgoo N; Osama Gaber A
Clin Transplant; 2011; 25(3):E250-6. PubMed ID: 21231963
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
Ciancio G; Burke GW; Gaynor JJ; Roth D; Sageshima J; Kupin W; Tueros L; Hanson L; Rosen A; Ruiz P; Miller J
Transplantation; 2008 Jul; 86(1):67-74. PubMed ID: 18622280
[TBL] [Abstract][Full Text] [Related]
37. Induction therapy in pediatric kidney transplant recipients discharged with a triple drug immunosuppressive regimen.
Sampaio MS; Poommipanit N; Kuo HT; Reddy PN; Cho YW; Shah T; Bunnapradist S
Pediatr Transplant; 2010 Sep; 14(6):770-8. PubMed ID: 20477974
[TBL] [Abstract][Full Text] [Related]
38. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
[TBL] [Abstract][Full Text] [Related]
39. Pediatric renal transplantation: a single center experience over 14 years.
Delucchi A; Ferrario M; Varela M; Cano F; Rodriguez E; Guerrero JL; Lillo AM; Wolff E; Godoy J; Buckel E; Gonzalez G; Rodriguez J; Cavada G
Pediatr Transplant; 2006 Mar; 10(2):193-7. PubMed ID: 16573606
[TBL] [Abstract][Full Text] [Related]
40. Kidney transplantation from pediatric donors in a single Chinese center.
Li JF; Liu J; Guo T; Pang XL; Liu L; Feng YH; Wang ZG; Feng GW; Shang WJ
Cell Biochem Biophys; 2014 Dec; 70(3):1713-7. PubMed ID: 24973957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
